Utility of Soluble ST2 biomarker to predict recurrence after electrical cardioversion in patients with atrial fibrillation

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Laila Gonzalez-Melchor

Hospital Doctor Jose Molina Orosa, Arrecife, Las Palmas (Spain)

6 More presentations in this session

Presentation thumbnail

Coronary artery disease ameliorates extracellular vesicle lncRNA PUNISHER regulates angiogenic response and endothelial cells function via NFkB-dependent mechanism

Doctor M. Hosen (Bonn, DE)

Abstract Slides

Presentation thumbnail

Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography

Doctor K. Ali (Dundee, GB)

Abstract Slides

Presentation thumbnail

The endoplasmic reticulum (ER) chaperone GRP78 is secreted during ER Stress and alleviates endothelial cell inflammation

Miss E. Repges (Bonn, DE)

Abstract Slides

Presentation thumbnail

Metabolic modulation as a common adaptive mechanism in patients with different subtypes of aortic valve stenosis

Doctor P. Bengel (Giessen, DE)

Abstract Slides

Presentation thumbnail

Cardiac troponin T degradation in end-stage renal disease patients appears to occur in vivo

Miss E. Denessen (Maastricht, NL)

Abstract Slides

Access the full session

Session thumbnail

Following disease progression by blood biomarkers

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Basic science

Congress Presentation

Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

Congress Presentation

DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources